Showing results (1531-1540 of 1,751) with videos related to

Sort By:
Pageof 176
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 24, 2012
Randomized phase II study of bortezomib, thalidomide, and dexamethasone with or without cyclophosphamide as induction therapy in previously untreated multiple myelomaHeinz Ludwig, Luisa Viterbo, Richard Greil, et al.
Scientific Reports|December 24, 2025
Late posttonsillectomy haemorrhage, differences in unilateral versus bilateral tonsillectomy, a retrospective epidemiological multicentric studyJan Vodicka, Viktor Chrobok, Martin Chovanec, et al.
Frontiers in Psychiatry|June 26, 2024
Age-specific risk factors of depression among the oldest-old - evidence from the multicenter AgeCoDe-AgeQualiDe studyMelanie Luppa, Alexander Pabst, Margrit Löbner, et al.
Addiction (Abingdon, England)|January 17, 2024
Safety of e-cigarettes and nicotine patches as stop-smoking aids in pregnancy: Secondary analysis of the Pregnancy Trial of E-cigarettes and Patches (PREP) randomized controlled trialFrancesca Pesola, Katie Myers Smith, Anna Phillips-Waller, et al.
Aging & Mental Health|February 22, 2020
Help-seeking for psychological distress and its association with anxiety in the oldest old - results from the AgeQualiDe cohort studyJohanna Katharina Hohls, Hans-Helmut König, Marion Eisele, et al.
Aging Clinical and Experimental Research|August 19, 2019
Correlates of hospitalization among the oldest old: results of the AgeCoDe-AgeQualiDe prospective cohort studyAndré Hajek, Christian Brettschneider, Marion Eisele, et al.
The Journal of Molecular Diagnostics : JMD|August 31, 2015
Minimal Residual Disease Detection by Droplet Digital PCR in Multiple Myeloma, Mantle Cell Lymphoma, and Follicular Lymphoma: A Comparison with Real-Time PCRDaniela Drandi, Lenka Kubiczkova-Besse, Simone Ferrero, et al.
Plos One|December 15, 2015
Longitudinal Predictors of Institutionalization in Old AgeAndré Hajek, Christian Brettschneider, Carolin Lange, et al.
The Oncologist|July 27, 2014
European perspective on multiple myeloma treatment strategies in 2014Heinz Ludwig, Pieter Sonneveld, Faith Davies, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 8, 2013
Gain(1)(q21) is an unfavorable genetic prognostic factor for patients with relapsed multiple myeloma treated with thalidomide but not for those treated with bortezomibJan Smetana, Kristina Berankova, Romana Zaoralova, et al.
Pageof 176